Independent testing confirms intended iron boride phase as conversion rises to 51%-62%; 1,400°C testing and larger-batch work advance the next stage of a potential U.S. mine-to-magnet supply chain ...
As part of its next phase of growth, Xcellon Biologics appointed co-founder Abhishake Chhibber as Chief Executive Officer to lead the company’s transformation into an end-to-end CRDMO for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results